➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Express Scripts
Harvard Business School
Medtronic
McKinsey

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

US Patent Family Members and Approved Drugs for Uruguay Patent: 35072

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for Uruguay Patent: UY35072

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
US Patent Number Estimated Patent Expiration Generic Name US Applicant US Tradename
  Start Trial 2032-10-09 insulin glargine recombinant Sanofi Aventis Us LANTUS
  Start Trial 2032-10-09 insulin glargine recombinant Sanofi Aventis Us LANTUS SOLOSTAR
  Start Trial 2032-10-09 insulin detemir Novo Nordisk LEVEMIR
  Start Trial 2032-10-09 metreleptin Aegerion MYALEPT
  Start Trial 2032-10-09 albiglutide Glaxosmithkline Llc TANZEUM
  Start Trial 2032-10-09 dulaglutide Eli Lilly And Co TRULICITY
  Start Trial 2032-10-09 insulin degludec Novo TRESIBA
>US Patent Number >Estimated Patent Expiration >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Johnson and Johnson
Moodys
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.